NR4A1 and metastatic carcinoma: The assessment of estrogen and progesterone receptor status in the primary tumor may not reflect the status in the recurrent or metastatic tumor, and thus a biopsy of recurrent or metastatic carcinomas for hormone receptor analysis may be helpful.